Skip to main content

DPP HIV-Syphilis receives CLIA Waiver: The First & Only FDA Approved, CLIA Waived* HIV-Syphilis Rapid Test

*CLIA Waived for fingerstick whole blood


Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK® Assay at Chembio Diagnostics Malaysia Facility


Launching Status COVID-19/Flu 15 Minute Visual Read Rapid Test in the USA


Launching DPP® SARS-CoV-2 Antigen System in Brazil


Announcing the receipt of CLIA Waiver for DPP HIV-Syphilis. Contact your local Chembio Representative for more information

CLIA Waved Badge

Stay up to date with our latest news.


Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG,…

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on…

Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

HAUPPAUGE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused…
About Us

We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care.

Our mission is to be a leader in the development, manufacturing and commercialization of diagnostic solutions. We are dedicated to delivering exceptional point-of-care products that are easy to use, fast and accurate.

Our Core Values: “RAPID”






Learn More
Investor Relations

Chembio is a leading point of care diagnostics company focused on detecting and diagnosing infectious diseases.

Our patented DPP® technology platform uses a small drop of blood from the fingertip and provides high-quality, cost-effective results in 15-20 minutes. Our products are sold globally, directly and through distributors, to hospitals, clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

Chembio Testing

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.

Subscribe to the Chembio Mailing List